- In January 2024, The Professional Society for Health Economics and Outcomes Research announced an expanded editorial scope and plans to transition its journal to a gold open access model
- In December 2023, Komodo Health was selected by the Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute at the University of Washington’s School of Pharmacy to collaborate on generating real-world insights. The partnership focuses on comparative outcomes and cost-effectiveness research and analytics within the U.S.
- In November 2023, Fishawack Health (FH), a leading commercialization partner for biopharmaceutical, medical technology, and wellness companies, expanded its Value, Evidence, and Access (VEA) capabilities through the acquisition of Policy Analysis Inc. (PAI), a U.S.-based health economics and outcomes research (HEOR) consultancy
- In November 2023, Curavit Clinical Research, a virtual contract research organization (VCRO), launched a tailored Health Economics and Outcomes Research (HEOR) service for clinical trials. By integrating HEOR into clinical trials, Curavit aims to provide pharmaceutical manufacturers with crucial insights into their products' value and market potential
- In May 2022, Trinity Life Sciences initiated a project to examine the impact of significant advancements and growth in Health Economics and Outcomes Research (HEOR) within the U.S.
- In May 2022, Cigna, a leading American multinational health and insurance company, introduced a new oncology consultation service aimed at improving health outcomes for its members
- In April 2022, Snowflake Inc., a cloud computing and data storage company, launched healthcare and life sciences cloud consulting services. These services enable organizations to securely centralize, integrate, and exchange critical and sensitive data at scale
